Valued at a market cap of $48.2 billion, Edwards Lifesciences Corporation (EW) is a medical technology company based in Irvine, California. It develops, manufactures, and markets advanced devices used to treat patients with serious heart conditions. The company is scheduled to announce its fiscal Q4 earnings for 2025 in the near future. Ahead of this event, analysts expect this healthcare company to report a profit of$0.61 per share, up 3.4% from $0.59 per share in the year-ago quarter. The company has ...